VeriChip shares jump after H1N1 patent license win

[Kat Kanning]

VeriChip shares jump after H1N1 patent license win
Mon Sep 21, 2009 3:11pm EDT

http://www.reuters.com/article/rbssTechMediaTelecomNews/idUSBNG49295720090921
Sept 21 (Reuters) - Shares of VeriChip Corp (CHIP.O)
tripled after the company said it had been granted an exclusive
license to two patents, which will help it to develop
implantable virus detection systems in humans.
The patents, held by VeriChip partner Receptors LLC, relate
to biosensors that can detect the H1N1 and other viruses, and
biological threats such as methicillin-resistant Staphylococcus
aureus, VeriChip said in a statement.
The technology will combine with VeriChip's implantable
radio frequency identification devices to develop virus triage
detection systems.
The triage system will provide multiple levels of
identification -- the first will identify the agent as virus or
non-virus, the second level will classify the virus and alert
the user to the presence of pandemic threat viruses and the
third level will identify the precise pathogen, VeriChip said
in a white paper published May 7, 2009.

[Kat Kanning]

More microchip craziness

Andrew Jack
The Financial Times
September 22, 209

Patients who fail to pop pills on time could soon benefit from having a chip on their shoulder, under a ground-breaking electronic system being developed by Novartis, the Swiss pharmaceuticals group.


The company is testing technology that inserts a tiny microchip into each pill swallowed and sends a reminder to patients by text message if they fail to follow their doctors' prescriptions.

The partnership with Proteus Biomedical, which originally developed the technology, is one of several alliances under development by Novartis as it and rival pharmaceuticals companies attempt to maintain high prices for innovative medicines by ensuring that they are taken as the doctor ordered. Pfizer's Health Solutions division has developed a system to telephone patients to encourage them to take medicine.

Joe Jimenez, head of pharmaceuticals at Novartis, said tests using the system – which broadcasts from the "chip in the pill" to a receiver on the shoulder – on 20 patients using Diovan, a drug to lower blood pressure, had boosted "compliance" with prescriptions from 30 per cent to 80 per cent after six months.

[jerryswife]

Just another way for big brother/Obamacare to control the masses.  Nanotechnology in pills.

http://www.naturalnews.com/029210_nanotechnology_medicines.html